Company / Financials
Aspira Women's Health Inc. Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$343.0K
FY2025 · +8475.0% YoY
Net Income
-$12.8M
FY2025 · +2.4% YoY
Profit Margin
-3726.0%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$5.5M
FY2025
Total Debt
$1.3M
-0.18x debt/equity
Equity
-$6.9M
FY2025
ROA
-234.2%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -89.08 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$343.0K+8475.0% YoYNet Income HistoryProfit after all expenses and taxes-$12.8M+2.4% YoYGross Profit HistoryRevenue minus cost of goods sold$5.9M+8.0% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$3.3M-10.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$7.9M+51.4% YoYSG&A Expense HistorySelling, general, and administrative expenses$8.0M-23.0% YoYR&D Expense HistoryResearch and development spending$2.9M-11.9% YoYIncome Tax HistoryTotal income tax expense-EPS (Basic) HistoryBasic earnings per share-$0.93+48.6% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$0.93+48.6% YoY